Use of antithrombin III concentrates to correct antithrombin III deficiency during vascular surgery
- 1 December 1995
- journal article
- case report
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 22 (6) , 804-807
- https://doi.org/10.1016/s0741-5214(95)70072-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Kinetics of Elimination of Antithrombin III Concentrate in Heparinized PatientsBritish Journal of Haematology, 2008
- Thrombosis during Pregnancy and Surgery in Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein SThrombosis and Haemostasis, 1994
- Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group [see comments]Blood, 1990
- Heat inactivation of human immunodeficiency virus in solutions of antithrombin IIITransfusion, 1989
- Transfusion Studies in Patients with Familial Antithrombin III (ATIII) Deficiency: Half‐disappearance Time of Infused ATIII and Influence of such Infusion on Platelet Life‐spanBritish Journal of Haematology, 1981
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977
- Inherited Antithrombin Deficiency Causing ThrombophiliaThrombosis and Haemostasis, 1965